Divergent roles for STAT4 in shaping differentiation of cytotoxic ILC1 and NK cells during gut inflammation

Gianluca Scarno,Julija Mazej,Mattia Laffranchi,Chiara Di Censo,Irene Mattiola,Arianna M Candelotti,Giuseppe Pietropaolo,Helena Stabile,Cinzia Fionda,Giovanna Peruzzi,Stephen R Brooks,Wanxia Li Tsai,Yohei Mikami,Giovanni Bernardini,Angela Gismondi,Silvano Sozzani,James P Di Santo,Christian A J Vosshenrich,Andreas Diefenbach,Massimo Gadina,Angela Santoni,Giuseppe Sciumè
DOI: https://doi.org/10.1073/pnas.2306761120
2023-10-03
Abstract:Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1) require signal transducer and activator of transcription 4 (STAT4) to elicit rapid effector responses and protect against pathogens. By combining genetic and transcriptomic approaches, we uncovered divergent roles for STAT4 in regulating effector differentiation of these functionally related cell types. Stat4 deletion in Ncr1-expressing cells led to impaired NK cell terminal differentiation as well as to an unexpected increased generation of cytotoxic ILC1 during intestinal inflammation. Mechanistically, Stat4-deficient ILC1 exhibited upregulation of gene modules regulated by STAT5 in vivo and an aberrant effector differentiation upon in vitro stimulation with IL-2, used as a prototypical STAT5 activator. Moreover, STAT4 expression in NCR+ innate lymphocytes restrained gut inflammation in the dextran sulfate sodium-induced colitis model limiting pathogenic production of IL-13 from adaptive CD4+ T cells in the large intestine. Collectively, our data shed light on shared and distinctive mechanisms of STAT4-regulated transcriptional control in NK cells and ILC1 required for intestinal inflammatory responses.
What problem does this paper attempt to address?